Literature DB >> 7790776

Interferon-alpha and interferon-gamma down-regulate the production of interleukin-8 and ENA-78 in human monocytes.

S Schnyder-Candrian1, R M Strieter, S L Kunkel, A Walz.   

Abstract

The two chemotactic cytokines interleukin-8 (IL-8) and epithelial neutrophil activating protein 78 (ENA-78) were recently shown to be potent chemoattractants and activators of neutrophil function and to be present in certain inflammatory diseases. We have studied the effects of recombinant and natural interferon-alpha (IFN-alpha) and of recombinant interferon gamma (rIFN-gamma) on the production of IL-8 and ENA-78 in lipopolysaccharide- and interleukin-1-stimulated human monocytes. Both types of interferons showed a strong, concentration-dependent inhibition of neutrophil-stimulating bioactivity. Similarly, the secretion of IL-8 and ENA-78 was also inhibited by up to 73%. Northern blot experiments demonstrated that IFN-alpha decreases the steady-state levels of IL-8 and ENA-78 mRNA in monocytes, suggesting that IFN-alpha as well as IFN-gamma may control the expression of neutrophil chemotactic cytokines at the mRNA level.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7790776     DOI: 10.1002/jlb.57.6.929

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  19 in total

1.  Gene regulatory and clinical effects of interferon β in patients with metastatic melanoma: a phase II trial.

Authors:  Ernest C Borden; Barbara Jacobs; Emese Hollovary; Lisa Rybicki; Paul Elson; Thomas Olencki; Pierre Triozzi
Journal:  J Interferon Cytokine Res       Date:  2011-01-15       Impact factor: 2.607

2.  Overexpression of CXCL5 is associated with poor survival in patients with pancreatic cancer.

Authors:  Aihua Li; Jonathan King; Aune Moro; Mark D Sugi; David W Dawson; Jeffrey Kaplan; Gang Li; Xuyang Lu; Robert M Strieter; Marie Burdick; Vay Liang W Go; Howard A Reber; Guido Eibl; O Joe Hines
Journal:  Am J Pathol       Date:  2011-03       Impact factor: 4.307

3.  Cell cycle-dependent expression of CXC chemokine receptor 3 by endothelial cells mediates angiostatic activity.

Authors:  P Romagnani; F Annunziato; L Lasagni; E Lazzeri; C Beltrame; M Francalanci; M Uguccioni; G Galli; L Cosmi; L Maurenzig; M Baggiolini; E Maggi; S Romagnani; M Serio
Journal:  J Clin Invest       Date:  2001-01       Impact factor: 14.808

4.  IL-1α modulates neutrophil recruitment in chronic inflammation induced by hydrocarbon oil.

Authors:  Pui Y Lee; Yutaro Kumagai; Yuan Xu; Yi Li; Tolga Barker; Chao Liu; Eric S Sobel; Osamu Takeuchi; Shizuo Akira; Minoru Satoh; Westley H Reeves
Journal:  J Immunol       Date:  2010-12-29       Impact factor: 5.422

5.  Flavonoids inhibit COX-1 and COX-2 enzymes and cytokine/chemokine production in human whole blood.

Authors:  Daniela Ribeiro; Marisa Freitas; Sara M Tomé; Artur M S Silva; Stefan Laufer; José L F C Lima; Eduarda Fernandes
Journal:  Inflammation       Date:  2015-04       Impact factor: 4.092

6.  Biochemical and morphological characterization of vascular and lymphocytic interleukin-4 receptors.

Authors:  B Schnyder; S M Lugli; S Schnyder-Candrian; V M Eng; R Moser; J Banchereau; B Ryffel; B D Car
Journal:  Am J Pathol       Date:  1996-10       Impact factor: 4.307

7.  Interleukin-18 (IFNgamma-inducing factor) induces IL-8 and IL-1beta via TNFalpha production from non-CD14+ human blood mononuclear cells.

Authors:  A J Puren; G Fantuzzi; Y Gu; M S Su; C A Dinarello
Journal:  J Clin Invest       Date:  1998-02-01       Impact factor: 14.808

Review 8.  Pseudomonas aeruginosa biofilms in disease.

Authors:  Lawrence R Mulcahy; Vincent M Isabella; Kim Lewis
Journal:  Microb Ecol       Date:  2013-10-06       Impact factor: 4.552

Review 9.  Interferon-alpha and its effects on post-transplant lymphoproliferative disorders.

Authors:  A Faro
Journal:  Springer Semin Immunopathol       Date:  1998

10.  Successful immunotherapy with IL-2/anti-CD40 induces the chemokine-mediated mitigation of an immunosuppressive tumor microenvironment.

Authors:  Jonathan M Weiss; Timothy C Back; Anthony J Scarzello; Jeff J Subleski; Veronica L Hall; Jimmy K Stauffer; Xin Chen; Dejan Micic; Kory Alderson; William J Murphy; Robert H Wiltrout
Journal:  Proc Natl Acad Sci U S A       Date:  2009-11-05       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.